XML 20 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Preferred Stock A
Common Stock
Additional paid-in capital
Treasury shares
Accumulated other comprehensive income (loss)
Accumulated deficit
Balance at Dec. 31, 2016 $ (831)   $ 3 $ 23,391 $ (747) $ 5 $ (23,483)
Balance, Shares at Dec. 31, 2016     3,023,043        
Beneficial conversion feature in respect to convertible loan 811     811      
Classification of derivative liability for right to future investment into equity 280     280      
Issuance of units consisting of common stock, preferred stock A and detachable warrants, net of issuance costs (Note 12h) 966   $ 1 965      
Issuance of units consisting of common stock, preferred stock A and detachable warrants, net of issuance costs (Note 12h), shares     860,987        
Conversion of Preferred stock into Common stock (Note 12i)            
Exercise of options into common stock 21   [1] 21      
Exercise of options into common stock, shares     31,439        
Cancellation of treasury shares with respect to reverse recapitalization     (747) 747    
Shares issued with respect to reverse recapitalization 298   [1] 298      
Shares issued with respect to reverse recapitalization, Shares     435,139        
Amount allocated to the repurchase of beneficial conversion feature in convertible loans (2,800)     (2,800)      
Amount allocated to the right for future investment - loan 2016 upon 2017 modification 44     44      
Amount allocated to the right for future investment - loan 2017 upon 2017 modification 1,115     1,115      
Deemed dividend with respect to the repurchase of right for future investment (3)           (3)
Stock-based compensation 19     19      
Foreign currency translation adjustment (78)         (78)  
Changes in unrealized gains on marketable equity securities 26         26  
Net loss (2,966)           (2,966)
Balance at Dec. 31, 2017 (3,098)   $ 4 23,397 (47) (26,452)
Balance, Shares at Dec. 31, 2017     4,350,608        
Cumulative effect adjustment from transition to ASU 2016-01 (see note 2b)       (26) 26
Issuance of shares with respect to exercise of PIPE warrants and right for future investment (see note 12d) 1,145   $ 1 1,144  
Issuance of shares with respect to exercise of PIPE warrants and right for future investment (see note 12d), Shares     788,658        
Issuance of units consisting of common stock, preferred stock A and detachable warrants, net of issuance costs (Note 12h) 3,915 $ 1 $ 3 3,911      
Issuance of units consisting of common stock, preferred stock A and detachable warrants, net of issuance costs (Note 12h), shares   1,350 3,100,000        
Conversion of Preferred stock into Common stock (Note 12i) [1] [1]        
Conversion of Preferred stock into Common stock (Note 12i), Shares   (440) 440,000        
Amount allocated to the repurchase of beneficial conversion feature in convertible loans (1,918)     (1,918)      
mount allocated to the right for future investment - loan 2016 upon 2018 modification (note 8) 952     952      
Amount allocated to the right for future investment - loan 2017 upon 2018 modification (note 8 1,444     1,444      
Deemed dividend with respect to the repurchase of right for future investment (292)         (292)
Stock-based compensation 1,343   $ 1 [1] 1,342      
Stock-based compensation, Shares     278,284        
Net loss (3,279)           (3,279)
Balance at Dec. 31, 2018 $ 212 $ 1 $ 9 $ 30,272 $ (73) $ (29,997)
Balance, Shares at Dec. 31, 2018   910 8,957,550        
[1] Representing amount less than $1